Updated on 8 May 2015
China's Concord Medical has partnered with US cancer centre
Singapore: China based Concord Medical Services, a hospital management solution provider has signed a multi-year strategic development agreement with the University of Texas MD Anderson Cancer Center, a cancer research, treatment and education center.
CCM and MD Anderson will collaborate to develop a multidisciplinary cancer care, subspecialized and research-driven oncology program and state-of-art oncology facilities to optimize patient experience and improve cancer care in China and Singapore.
MD Anderson will provide CCM with strategic counsel and programmatic services to support the development and implementation of a multidisciplinary oncology program with emphasis on clinical quality, patient safety, training and education, as well as research and development programs. The agreement, which is the first of its kind for MD Anderson in Asia, will be an exclusive collaboration at CCM's new cancer facilities in Shanghai and Beijing, and the collaboration exclusivity will cover most of the provinces in China, and in Singapore. The organizations will also work collaboratively as CCM develops a new cancer hospital in Guangzhou, China.
In the future, CCM's cancer hospitals in China and Singapore will pursue to qualify for MD Anderson Cancer Network's Associate membership program, a co-branded clinical care, research and delivery partnership, which includes clinical integration with MD Anderson.
"We are very pleased to enter into a comprehensive, exclusive collaboration with MD Anderson," commented Dr Jianyu Yang, chairman and chief executive officer of Concord Medical.